2m 2m 2m 2m 2m 2m 2m
IMMUNEERING-A (IMRX)
NASDAQ
$3.82-$0.03 (-0.88%)
Price as of Nov 11, 2026 7:17 PM EST- $249.3MMarket Cap
- -42.88%1-Year Change
- BiotechnologyIndustry
IMMUNEERING-A (IMRX)
$3.82-$0.03 (-0.88%)
IMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.85 | ||
Change | +$0.20 (+5.48%) | ||
Open | $3.66 | ||
High | $3.90 | ||
Low | $3.64 | ||
Previous Close | $3.65 | ||
Volume | 769,413 | ||
30-Day Average Volume | 770,780 | ||
1-Week Change | 4.62% | ||
1-Month Change | -2.28% | ||
1-Year Change | -42.88% | ||
3-Year Change | -25.75% | ||
5-Year Change | -86.88% | ||
Fundamentals | |||
Shares Outstanding | 64.8M | ||
Total Assets | $182.6M | ||
Market Cap | $249.3M | ||
Enterprise Value | $191.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$24.2M | ||
Free Cash Flow | -$16.8M | ||
EBIT | -$24.2M | ||
EBITDA | -$24.2M | ||
Net Working Capital | $139.9M | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue